Gaudium IVF & Women Health IPO is a bookbuilt issue of ₹165.00 crores. It combines a fresh issue of 1.14 crore shares aggregating to ₹90.00 crore and an offer for sale of 0.95 crore shares aggregating to ₹75.00 crore.
The IPO opens for subscription on February 20, 2026 and closes on February 24, 2026. The allotment is expected to be finalised on Wednesday, February 25, 2026. The price band for the IPO is set at ₹75 to ₹79 per share, and the minimum lot size for an application is 189 shares.
Company Summary
Incorporated in March 2015, Gaudium IVF and Women’s Health Limited has engaged in In Vitro Fertilisation (IVF) treatments throughout India and has expanded into several states, utilising a hub-and-spoke model.
The company operates over thirty locations, which include seven hubs (centres) and twenty-eight spokes. The organisation has entered into a strategic alliance with Infertility Experts, known as Spokes, to achieve the mutual objective of raising awareness regarding Assisted Reproductive Technology (ART) and In Vitro Fertilization (IVF) treatments.
The company serves patients from various countries, including Canada, the United Kingdom, the United States, Kenya, South Africa, and Oman.
The company has centres in major cities, including two in Delhi (Janakpuri and Kailash Colony), one each in Mumbai (Khar West), Ludhiana, Srinagar, Patna, and Bangalore, covering key locations across India.
The company offers specialized fertility services, including In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), Intrauterine Insemination (IUI), and ovulation induction. Our treatments are designed for various infertility challenges for both genders. We also provide comprehensive gynaecological care for PCOD/PCOS and endometriosis, as well as high-risk pregnancy management for women with complex fertility histories or health conditions.
The facilities provide a comprehensive range of male infertility treatments, including advanced sperm retrieval techniques.
Company Strengths
- Patient-Centric Approach
- Expert team
- Using next-gen INTEGRA Ti labs for ICSI.
- Highly Technical USG Guided Services
- Established central hubs in prime urban locations, including Mumbai, Bangalore, Delhi NCR, and Patna.
- Asset Light Business Model
Company Financials
| Period Ended | 30 Sep 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
| Assets | 106.62 | 88.51 | 51.01 | 36.63 |
| Total Income | 49.75 | 70.96 | 48.15 | 44.26 |
| Profit After Tax | 12.51 | 19.13 | 10.32 | 13.53 |
| EBITDA | 18.95 | 28.63 | 19.27 | 20.07 |
| Net Worth | 58.85 | 46.3 | 26.99 | 22.73 |
| Reserves and Surplus | 28.16 | 15.6 | 26 | 21.74 |
| Total Borrowing | 22.51 | 18.93 | 15.73 | 9.78 |
| Amount in ₹ Crores | ||||
Objectives of IPO
- Funding capital expenditure towards the establishment of the New IVF Centers of the Company.
- Repayment/pre-payment, in full or in part, of certain outstanding loans availed by the Company.
- General Corporate Purpose
Promoters of the company
The Promoters of the company are Dr. Manika Khanna, Dr. Peeyush Khanna, and Vishad Khanna.
IPO Details
| IPO Date | February 20, 2026 to February 24, 2026 |
| Listing Date | February 27, 2026 |
| Face Value | ₹5 per share |
| Price Band | ₹75 to ₹79 per share |
| Lot size | 189 shares |
| Total Issue size | 2,08,86,200 shares (aggregating upto ₹165.00 Cr ) |
| Fresh Issue | 1,13,92,500 shares (aggregating upto ₹90.00 Cr ) |
| Offer for Sale | 94,93,700 shares of ₹5 (aggregating upto ₹75.00 Cr ) |
| Issue type | Bookbuilding IPO |
| Listing at | NSE, BSE |
| Share Holding Pre Issue | 6,13,94,384 shares |
| Share Holding Post Issue | 7,27,86,884 shares |
Lot Allocation Details
| Application | Lots | Shares | Amount |
| Retail (Min) | 1 | 189 | ₹14,931.00 |
| Retail (Max) | 13 | 2,457 | ₹1,94,103.00 |
| S-HNI (Min) | 14 | 2,646 | ₹2,09,034.00 |
| S-HNI (Max) | 66 | 12,474 | ₹9,85,446.00 |
| B-HNI (Min) | 67 | 12,663 | ₹10,00,377.00 |
Allotment Schedule
| Basis of Allotment | Wed, 25 Feb, 2026 |
| Initiation of Refunds | Wed, 25 Feb, 2026 |
| Credit of Shares to Demat | Thu, 26 Feb, 2026 |
| Tentative Listing Date | Fri, 27 Feb, 2026 |
IPO Reservation
| Investor Category | Shares Offered |
| QIB Shares Offered | Not more than 50% of the Net Issue |
| Retail Shares Offered | Not less than 35% of the Net Issue |
| NII Shares Offered | Not less than 15% of the Net Issue |
Source – SEBI, Chittorgarh
To check allotment, click here
Download NOVO App!
Invest in Zero-commission Direct Mutual funds, IPO, Sovereign Gold bonds, Government bills, and Corporate bonds.
